# 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China

> **NCT00799968** · PHASE4 · COMPLETED · sponsor: **Beijing Chao Yang Hospital** · enrollment: 129 (actual)

## Conditions studied

- Pulmonary Embolism
- Thromboembolism

## Interventions

- **DRUG:** Urokinase
- **DRUG:** Urokinase

## Key facts

- **NCT ID:** NCT00799968
- **Lead sponsor:** Beijing Chao Yang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2008-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799968, "12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00799968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*